Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$508K Sell
3,950
-4
-0.1% -$468 0.1% 99
2026
Q1
$476K Buy
3,954
+500
+14% +$57.7K 0.11% 89
2025
Q4
$364K Buy
3,454
+6
+0.2% +$563 0.09% 103
2025
Q3
$289K Hold
3,448
0.07% 111
2025
Q2
$273K Hold
3,448
0.07% 113
2025
Q1
$309K Hold
3,448
0.09% 107
2024
Q4
$343K Sell
3,448
-193
-5% -$19.9K 0.1% 99
2024
Q3
$413K Sell
3,641
-32
-0.9% -$3.8K 0.12% 91
2024
Q2
$455K Buy
3,673
+36
+1% +$4.64K 0.14% 83
2024
Q1
$480K Hold
3,637
0.15% 83
2023
Q4
$397K Buy
3,637
+124
+4% +$12.9K 0.14% 83
2023
Q3
$362K Buy
3,513
+26
+0.7% +$2.8K 0.14% 81
2023
Q2
$402K Buy
+3,487
New +$396K 0.15% 79

Other funds holding MRK

Ballast Inc's MRK Position: Q2 2026 in Review

Ballast Inc reduced its Merck (MRK) stake by 0.1% in Q2 2026, selling an estimated $468 and leaving 3,950 shares worth $508K. The position accounts for 0.1% of the portfolio, ranked #99.

Ballast Inc first reported a position in MRK in Q2 2023 and has held it in 13 quarters since. 3,820 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Ballast Inc held 3,950 shares of Merck worth $508K as of Q2 2026.
  • Ballast Inc sold 4 Merck shares in Q2 2026, an estimated $468.
  • Merck made up 0.1% of Ballast Inc's portfolio in Q2 2026, its #99 holding.
  • Ballast Inc first reported a position in Merck in Q2 2023 and has held it in 13 quarters since.
  • 3,820 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Ballast Inc's 13F filing for Q2 2026, filed 10 Jul 2026.